Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Aytu BioPharma Announces FDA Clearance Of Investigational New Drug Application For AR101/Enzastaurin In Vascular Ehlers-Danlos Syndrome


Benzinga | Dec 13, 2021 08:08AM EST

Aytu BioPharma Announces FDA Clearance Of Investigational New Drug Application For AR101/Enzastaurin In Vascular Ehlers-Danlos Syndrome






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC